-
281
-
282
-
283
Responsible research in health disparities using the Adolescent Brain Cognitive DevelopmentSM (ABCD) study
Published 2025-01-01Get full text
Article -
284
Private, public, and bottled drinking water: Shared contaminant-mixture exposures and effects challenge
Published 2025-01-01Get full text
Article -
285
-
286
Caloric labels do not influence taste pleasantness and neural responses to erythritol and sucrose
Published 2025-03-01Get full text
Article -
287
Classification and Characteristics of Pain Associated with Parkinson’s Disease
Published 2016-01-01Get full text
Article -
288
Fully integrated wearable control system for micro/nanorobot navigation
Published 2025-01-01Get full text
Article -
289
Extraction-Free, Direct Determination of Caffeine in Microliter Volumes of Beverages by Thermal Desorption-Gas Chromatography Mass Spectrometry
Published 2020-01-01“…A 5 μL aliquot was introduced to the thermal desorption unit, dried, and thermally desorbed to the GC/MS. …”
Get full text
Article -
290
Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and future
Published 2025-04-01“…To enhance comprehension of clinical situations, this article provides a comprehensive analysis of the clinical efficacy of nerve conduits approved by the United States Food and Drug Administration. It proposes that the initial six months post-transplantation is a critical window period for evaluating their efficacy. …”
Get full text
Article -
291
-
292
Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types
Published 2025-02-01“…The KEYNOTE 158 trial supported United States Food and Drug Administration (FDA) approval of the Foundation Medicine test (FoundationOneCDx) at TMB≥10 mut/Mb as a companion diagnostic (CDx) for single-agent pembrolizumab in second+line. …”
Get full text
Article -
293
-
294
-
295
Sarilumab is not Inferior to Tocilizumab in the Treatment of Cytokine Release Syndrome in COVID-19
Published 2023-12-01Get full text
Article -
296
-
297
-
298
Challenges, progress, and opportunities in clinical toxicology in Nepal: a narrative review
Published 2025-12-01Get full text
Article -
299
-
300
Real-World Health Care Outcomes and Costs Among Patients With Juvenile Idiopathic Arthritis in Spain
Published 2023-12-01“…**Methods:** Children were enrolled in this 24-month observational, multicentric, cross-sectional, retrospective study (N = 107) if they had been treated with biologic disease-modifying anti-rheumatic drugs (bDMARDs), had participated in a previous study (ITACA), and continued to be followed up at pediatric rheumatology units at 3 tertiary Spanish hospitals. …”
Get full text
Article